Skip to content

Education Center: Webinars & CE

amd-ebook-lg2

Get a Free E-Book

Practical Guidelines for the Treatment of AMD

Comprehensive, evidence-based guidelines include the latest information on AMD classification, diagnosis, staging, and treatment.

Download

Diagnosing and Treating Early AMD at Your Practice

Advances in earlier diagnosis for AMD has made it possible for Primary Eye Care professionals to own AMD diagnosis and management. However, since this information is so new, it’s been difficult for clinicians to keep up with the science and understand how patients can benefit.

Watch this recording of our panel of experts who are leading the charge in AMD care as they answer questions and share practical knowledge for how they’ve successfully integrated AMD management into their medically oriented practices.

Moderator and Panel:

Vicki Dzurinko, OD
Moderator
MacuLogix
Jeffry Gerson, OD
Grin Eye Care
Olathe, KS
Pamela Lowe, OD
Professional Eye Care
Niles, IL
Allan Hudson, OD
High Desert VS
Redmond, OR

Who Said There’s Nothing You Can Do About Early AMD?

Presenter:

Ian Cameron
Independent Prescribing Optometrist in Edinburgh, United Kindgom

As optometrists, a diagnosis of AMD often means the end of the line for us. Late stage AMD needs urgent specialist intervention and earlier forms require the patient to do all the work with nutrition and self-monitoring on Amsler grids. We’re in the middle and keen to help. But what can we offer?

In this recorded webinar, Ian Cameron explains the underlying pathology, showing us the importance of early AMD diagnosis with dark adaptation testing, and discusses current treatment options that you can integrate into practice right now for the benefit of your patients.

United Kingdom optometrists and dispensing opticians can earn 1 CET point.

DeviceTalks Tuesdays

Panel:

Headshot of Jeffrey Champagne from MPR Associates

Gregory Jackson, PhD
Chief Technology Officer, MacuLogix

Jeffrey Champagne
Director of Business Development, MPR Associates

Craig Mauch
Director of Product Design, MPR Associates 

Headshot of Craig Mauch of MPR Associates

Learn more about the engineering and design that went into creating the breakthrough AdaptDx Pro™ dark adaptometer. Join Gregory Jackson, PhD, MacuLogix, and Jeffrey Champagne, and Craig Mauch from MPR, our engineering partner, as they share the story of the AdaptDx Pro.

AMD: Better Outcomes Start with You

Presenter:

Jeffry Gerson, OD, FAAO
Grin Eye Care, Olathe, KS

Headshot of Dr. Jeffry Gerson from Grin Eye Care in Olathe, Kansas

As AMD becomes a bigger problem in the general patient population, it becomes more important to detect it earlier and treat it appropriately. This lecture will discuss what optometrists can do to help with risk education, prevention, early detection and treatment.

This recorded webinar presentation discusses risk factors, early diagnosis, diet and lifestyle considerations, dark adaptation, OCT and autofluorescent changes, as well as current and future treatments of AMD.

United Kingdom optometrists and dispensing opticians can earn 1 CET point.

Practical Guidelines for the Treatment of AMD

Presenter:

Jeffry Gerson, OD, FAAO
Grin Eye Care, Olathe, KS

Headshot of Dr. Jeffry Gerson from Grin Eye Care in Olathe, Kansas

Over the past 15 years, tremendous advances have been made in regard to our understanding of age-related macular degeneration (AMD). However, information overload has made it difficult for clinicians to keep up with the science, much less understand the implications for patient care. This webinar brings together the latest information to deliver practical, evidence-based guidelines for the treatment of AMD that can be implemented in a medically-oriented practice.

Contemporary AMD Management for the Optometrist

Presenter:

Damon Dierker, OD, FAAO
Eye Surgeons of Indiana

Headshot of Dr. Damon Dierker from Eye Surgeons of Indiana

In this webinar, Dr. Dierker answers the following questions:

  • What exactly is AMD?
  • When can we confidently make the diagnosis?
  • How often should AMD patients be monitored?
  • When is special testing indicated?
  • What advice should we be giving patients if we use an evidence-based approach?
  • What can we really do that makes a difference in patients with AMD?

The ABCs of Marketing for ECPs (3-part series)

Ever thought about promoting your practice, but didn’t know where to start? Access our educational webinar series, Marketing Mondays, where three of MacuLogix’s marketing gurus will point you in the right direction.

AMD: Better Outcomes Start with You

Presenters:

Headshot of Dr. Shawn A. Lewis, MD from Retina Associates of Cleveland

Shawn A. Lewis, MD
Retina Associates of Cleveland

Mark F. Pyfer, MD
Northern Ophthalmic Associates; Wills Eye Hospital

Headshot of Dr. Mark F. Pyfer, MD from Northern Ophthalmic Associates; Wills Eye Hospital

In this webinar, Dr. Lewis and Dr. Pyfer discuss:

  • ​The current prevalence of AMD
  • Identifying subclinical AMD with Dark Adaptation testing
  • Using the AdaptDx® to detect and monitor AMD
  • How the AdaptDx can improve patient care and practice revenue

Dark Adaptation, the AdaptDx and Management of AMD

Presenters:Headshot of Dr. Richard Rosen, MD; Professor of Ophthalmology and Director of the Retinal Service at New York Eye and Ear Infirmary

​Richard Rosen, MD
Professor of Ophthalmology and Director of the Retinal Service at New York Eye & Ear Infirmary
Glenn Corbin, ODHead of Wyomissing Optometric Center and Adjunct Professor at Pennsylvania College of Optometry

Headshot of Dr. Glenn Corbin from Wyomissing Optometric Center, one of the first AdaptDx users

In this webinar, Dr. Rosen and Dr. Corbin discuss:

  • ​The science behind Dark Adaptation.
  • Why dark adaptation is a highly sensitive and specific assessment of AMD.
  • The role Dark Adaptation and the AdaptDx can play in your practice as your manage more and more AMD patients.

Videos

Eye care professionals share how AdaptDx Pro benefits their practices, while patients explain how an AMD diagnosis with the device changed their lives.

E-Books

Evidence-based guides include the latest information on AMD classification, diagnosis, staging and treatment.

Research

Compelling research proves MacuLogix dark adaptometers reveal the earliest biomarkers of AMD.

Partner with MacuLogix

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program to help you achieve your patient care and practice revenue goals.

Contact Our Sales Team

As the AMD experts, our sales team is here to answer your questions about the clinical and financial benefits of the AdaptDx Pro.